Skip to main content

Day: January 5, 2022

SharpLink Gaming Acquires FourCubed, Owner of the Industry’s Leading iGaming and Affiliate Marketing Network Comprised of Over 12,000 Sub-Affiliates

Strategic Acquisition Expected to Unlock and Fuel Conversions and Customer Lifetime Value of SharpLink’s 2.5 Million and Growing Base of Fantasy and Sports Game Players MINNEAPOLIS, Jan. 05, 2022 (GLOBE NEWSWIRE) — SharpLink Gaming Ltd. (Nasdaq:SBET) (“SharpLink” or the “Company”), a pioneer of game-changing technological solutions and experienced-based services for the U.S. online sports betting industry, today announced that it has acquired certain assets of FourCubed Management, LLC and 6t4 Company (collectively, “FourCubed”), including FourCubed’s iGaming and affiliate marketing network focused on delivering quality traffic and player acquisitions, retention and conversions to iGaming operator partners worldwide. SharpLink has acquired certain assets of FourCubed for total consideration of $8.15 million, which consists of $6.5...

Continue reading

Amazon and Stellantis Collaborate to Introduce Customer-Centric Connected Experiences Across Millions of Vehicles, Helping Accelerate Stellantis’ Software Transformation 

Amazon and Stellantis Collaborate to Introduce Customer-Centric Connected Experiences Across Millions of Vehicles, Helping Accelerate Stellantis’ Software Transformation  Amazon and Stellantis will collaborate to deliver software solutions for Stellantis’ new digital cabin platform, STLA SmartCockpit, starting in 2024 Stellantis selects AWS as its preferred cloud provider for vehicle platforms to deliver on its long-term, software-focused vision AWS and Stellantis to launch collaborative engineering and innovation initiatives and tools to accelerate time to market for new digital products and upskill Stellantis’ global workforce Amazon to be the first commercial customer for the new Ram ProMaster Battery Electric Vehicle (BEV) in 2023, further expanding Amazon’s sustainable delivery network SEATTLE and AMSTERDAM —January 5, 2022—Amazon...

Continue reading

DZS and Irby Utilities Work Together to Help 4-County Electric Power Association Bring Gigabit+ Broadband and Smart Grid Connectivity to Rural Mississippi

Electric cooperative leverages CARES and RDOF programs and DZS/Irby Utilities expertise to aggressively build out world-class broadband network to over 40,000 homes and businesses PLANO, Texas, Jan. 05, 2022 (GLOBE NEWSWIRE) — DZS (NASDAQ: DZSI), a global leader in broadband connectivity platforms and communications software solutions, today announced the continued successful expansion of a major rural broadband transformation project being deployed by electric cooperative 4-County Electric Power Association (4-County) in East Central Mississippi in conjunction with DZS strategic partner Irby Utilities (Irby), a subsidiary of Sonepar USA who provides full scope fiber network solutions through its Technology and Communications business group. Now in its second year of buildout, 4-County has moved beyond its successful pilot of DZS...

Continue reading

Agile Therapeutics to Present at the Biotech Showcase and H.C. Wainwright BioConnect Virtual Conferences

PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced Chairman and Chief Executive Officer Al Altomari will present at the H.C. Wainwright BioConnect Virtual Conference taking place January 10-13, 2022, and at Biotech Showcase taking place January 10-12, 2022. Details of the presentations are as follows:Event: H.C. Wainwright BioConnect Virtual ConferenceDate: January 10-13, 2022Time: Presentation available on-demand starting at 7:00 a.m., ET on January 10, 2022   Event: Biotech ShowcaseDate: January 10-12, 2022Time: Presentation available on-demand starting at 11:00 a.m., ET on January 10, 2022The presentations will be accessible in the investor relations section of the Agile Therapeutics website here. About Agile Therapeutics,...

Continue reading

Oncotelic Initiates Phase 1 Trial Evaluating CA4P in Combination with Pembrolizumab for Melanoma

AGOURA HILLS, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), a leading developer of TGF-β therapeutics for oncology and virology, today announced that it has submitted a clinical study protocol to the United States Food and Drug Administration (“US FDA”) for the initiation of a Phase 1 Clinical Trial for CA4P, the Company’s Vascular Disrupting Agent, in combination with Anti-PD-1 (pembrolizumab) as a treatment for patients with Melanoma. The Phase 1 Clinical Trial is designated as S101: Phase 1, Prospective, Multicenter, Open-Label, Single Arm Study of Safety and Initial Efficacy of CA4P in Combination with anti-PD1 (pembrolizumab) in Patients with Recurrent Metastatic Cutaneous or Uveal Melanoma. CA4P has been evaluated in over 500 patients...

Continue reading

Healthcare Integrated Technologies Receives Notice from USPTO Allowing SafeSpace™ Trademark

Trademark approved for “Medical alarm monitoring services for senior living in Class 45” Knoxville, Tennessee, Jan. 05, 2022 (GLOBE NEWSWIRE) — Healthcare Integrated Technologies Inc. (“HITC”), a digital health enterprise monitoring solutions provider for the senior care field today announced receipt of notice from the United States Patent and Trademark Office (USPTO) advising approval of U.S. Application Serial No. 90609625, for the trademark “SafeSpace.” “This allows us to more actively invest in the branding and marketing of our unique remote sensing and monitoring products and services to our business customers in the senior lifestyle and senior living field,” commented Scott Boruff, CEO. “SafeSpace’ sums up the improved reliability, safety, and security our services provide to our senior living clients and their residents.” For...

Continue reading

Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor

ACTON, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”) a late-stage, pre-revenue diagnostics/medical device company focused on developing cost-effective, rapid, near-patient products for triage and monitoring of disease progression, today announced the appointment of Mark W. Feinberg, M.D. as Chief Medical Advisor. Dr. Feinberg will guide Bluejay’s clinical development programs and provide strategic medical and scientific leadership to the Company. “I am very pleased to welcome Mark on board as Chief Medical Advisor. I believe Mark’s expansive clinical background and strategic leadership skills will be invaluable as we seek to develop the Company’s first product, the Symphony IL-6 Test to determine patient acuity for sepsis triage and monitoring (“Symphony IL-6 Test), and to advance...

Continue reading

Visteon Brings High Perceptual Quality with Advanced Cockpit Display Technology to CES® 2022

Safety and a unified user experience highlight the Visteon Smart CockpitVisteon in-house technology drives performance and value through functional and physical integration TrueColor image enhancement delivers a premium quality display experience, even in extreme brightness to overcome glare and improve driver safety Active privacy display technology addresses driver distraction by keeping infotainment content visible only to passengers Digital assistant technology is fully integrated; future-looking Avatar Holographic Display technology delivers virtual assistantLAS VEGAS, Jan. 05, 2022 (GLOBE NEWSWIRE) — Visteon (NASDAQ: VC), a global technology company serving the mobility industry, will showcase its advanced display technology at CES® 2022 among an array of innovations that provide a superior user experience for driver...

Continue reading

Visteon Complements Industry-First Smart Wireless Battery Management System with Additional Electrification Technology

Intelligent Electrification Capability on Full Display at CES® 2022 Electrification electronics designed to support global growth of electric vehicles Power electronics capabilities beyond smartBMS innovation Visteon BMS systems provide OEMs with scalability across brands and vehicle segmentsLAS VEGAS, Jan. 05, 2022 (GLOBE NEWSWIRE) — Visteon (NASDAQ: VC), a leading global technology company serving the mobility industry, will showcase its suite of electrification electronics designed to support the global growth of electric vehicles and the electrification trends of OEM customers at CES® 2022. As the global mobility industry undergoes a once-in-a-century electric transformation, Visteon is evolving its electrification electronics capabilities to include a variety of intelligent systems for battery management and integrated...

Continue reading

Visteon Unveils Fourth-Generation SmartCore™ Domain Controller for Enhanced Safety and Connected Mobility

Fourth-generation SmartCore™ delivers high-quality intelligent cockpit experience across conventional and electric vehicle applications Solution for next generation cockpit architecture to address connected, electrified, and personalized experience Seamless support of multiple displays along with integrated infotainment, safety and security features Full support of artificial intelligence-based speech recognition and camera-domain integrationLAS VEGAS, Jan. 05, 2022 (GLOBE NEWSWIRE) — Visteon (NASDAQ: VC), a leading global technology company serving the mobility industry, debuted its fourth-generation SmartCore™ cockpit domain controller at CES® 2022, showcasing a solution designed to enable global automakers to deliver a more connected, personalized and safe driving experience. The modern intelligent cockpit experience includes...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.